Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy such as soblidotin use different ways to stop tumor
cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of soblidotin in treating patients who
have advanced or metastatic soft tissue sarcoma.